The Co-Inventor of BlackBerry Is Building Canada’s Quantum Brain Trust

March 1, 2018
By Bloomberg
It’s early days for quantum computers, the still mostly theoretical subatomic processors so powerful they can make our fastest supercomputer look like an abacus. Mike Lazaridis, the co-inventor of the BlackBerry, says that when it comes to quantum technology, he’s learned his lesson. He won’t be iPhoned again. (Read more …) 

Flosonics Raises $5 Million for Device Helping Hospitals Track Critically-ill Patients

January 29 2018
By Betakit
Sudbury-based FloSonics Medical has raised $5 million in funding led by iGan Partners. Other investors include Genesys Capital, MaRS Investment Accelerator Fund (IAF), Accel-RX, MaRS Catalyst, Angel One, and Northern Ontario Angels. “We’re very enthusiastic about the investors who partnered in the current financing round lead by iGan Partners. It marks a critical step in the commercial development of our proprietary FloPatch technology,” said Joe Eibl, CEO and co-founder of FloSonics Medical. “Our company is developing a non-invasive means of monitoring critically ill patients during the early stages of shock inside and outside the hospital.” (Read more …) 

MolecuLight Supporting Smarter Wound Care

January 18 2017
By Huffington Post
Smart bandage technology is something I’ve touched on a few times. Most of the time, the technology has involved being able to monitor the health of a wound without ‘undressing’ the bandage. Some take on a more active role however, such as administering insulin to manage blood glucose levels. A team from the University of Nebraska-Lincoln, Harvard Medical School and MIT believe their smart bandage could eventually heal wounds on its own. The work, which was documented in a recently published paper, consists of electrically conductive fibers that have been coated in a gel that can itself be loaded with antibiotics, painkillers, tissue-regenerating growth factors or other medications. (Read more …) 

FDA Plans New Medical-Device Approval Processes

December 11 2017
By Thomas M. Burton
WASHINGTON—The Food and Drug Administration plans new medical-device approval processes to speed products’ entry to the U.S. market, mirroring the desires of industry and President Donald Trump to clear barriers to new business. FDA commissioner Scott Gottlieb, who has long espoused speedier steps to promote innovation, in an interview called for “progressive,” or stepped, approvals of certain devices that would allow them to go to market with initial approvals, with further evidence to assess performance coming later. That would entail more risk to patients initially than current procedures where clinical trials or other evidence come before market launch. (more…)   

The Blockchain Revolution Has Made its Way to Healthcare

November 29 2017
By Bernard Marr
The blockchain revolution has made its way to the healthcare industry, and it’s only the beginning of what’s possible. Healthcare Rallies for Blockchain, a study from IBM, found that 16% of surveyed healthcare executives had solid plans to implement a commercial blockchain solution this year, while 56% expected to by 2020. Healthcare companies, tech innovators and the rest of the healthcare industry are grappling with what’s possible now and what blockchain could solve in the future.

eSight Visit: iGan Analyst tests virtual reality glasses on family member with Stargardt Disease

December 1 2018
Anand Ganeshalingam
It was a cold bright day in November, and the clocks were striking ten. A crowd was bustling through Toronto’s union station, and my uncle, standing next to me, counted the chimes quietly on his fingers. He has Stargardt Disease and can’t see the clock across the room, so he counts the chimes to tell the time. We were on our way to meet with eSight eye-wear, located conveniently close to union station, at Front and University.

Why Immigrants Make Great Entrepreneurs

November 26 2017
By Wall Street Journal

The Unseen Perils of Crowdfunding for Investors

November 26 2017
By The Wall Street Journal
Letting small investors buy shares in startups sounds like a great way for budding companies to raise cash. But it could be dangerous for the people putting up the money. In a paper published in the journal Business Horizons, Melissa S. Baucus, formerly of the University of Otago in New Zealand, and Cheryl R. Mitteness of Northeastern University say it’s easy for swindlers to circumvent safeguards in the Jumpstart Our Business Startups Act, the 2012 federal law allowing startups to raise up to $1 million annually from retail investors.
“There’s too much opportunity” for Ponzi schemes and other shady projects, says Dr. Baucus, now at Texas State University.

Quandl is investors’ secret weapon to beating the market

Claire Brownell
Hedge funds are willing to pay handsomely for Quandl’s alternative data because it helps them achieve alpha, or market-beating returns, that are harder and harder to come by as information becomes easier to find and analyze. (more…)  

Thomson Reuters pledges $100-million to growing Toronto technology hub

James Bradshaw
“Thomson Reuters Corp. plans to invest $100-million (U.S.) to help build a permanent home for its growing Toronto technology hub. The news and information company has snapped up naming rights and all of the commercial office space in a major redevelopment of the former Southam Press Building. Sitting at the corner of Duncan Street and Adelaide Street West, the original brick structure with a history steeped in journalism was built in 1908.”